Oscar Health (OSCR) to Announce Quarterly Earnings on Tuesday

Oscar Health (NYSE:OSCR) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company posted ($1.05) earnings per share. Oscar Health’s revenue was up 43.9% on a year-over-year basis. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Trading Down 0.4 %

Shares of NYSE:OSCR opened at $18.02 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. Oscar Health has a 52-week low of $4.72 and a 52-week high of $18.69. The company has a 50-day simple moving average of $15.30 and a 200 day simple moving average of $11.76. The company has a market capitalization of $4.14 billion, a P/E ratio of -15.02 and a beta of 1.66.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. The Goldman Sachs Group raised their target price on shares of Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. Wells Fargo & Company upped their target price on Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Finally, Raymond James began coverage on Oscar Health in a research note on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Oscar Health has a consensus rating of “Moderate Buy” and an average target price of $13.50.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.